Drug-induced liver injury Clinical Trials
Conditions / Drug-induced liver injury
Delta Trials tracks 45 clinical trials for Drug-induced liver injury in its publicly accessible dataset. Among the listed trials, 7 open for participant enrollment and 18 trials have reached completion. This research is carried out at 161 clinical sites around the world. An additional 20 trials have active registrations outside the recruiting and completed categories. Since 2020, 4 trials have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
45
Total Trials
7
Recruiting
18
Completed
20
Other Active
4
Terminated since 2020
161
Study Locations
Browse by location (161 total)
- Beijing, China 14 trialsAll trials in Beijing, China
- Shanghai, China 4 trialsAll trials in Shanghai, China
- Nanjing, China 3 trialsAll trials in Nanjing, China
- Ho Chi Minh City, Vietnam 3 trialsAll trials in Ho Chi Minh City, Vietnam
- Seoul, South Korea 3 trialsAll trials in Seoul, South Korea
- Ho Chi Minh City, Vietnam 3 trialsAll trials in Ho Chi Minh City, Vietnam
- Chengdu, China 3 trialsAll trials in Chengdu, China
- Denver, United States 2 trialsAll trials in Denver, United States
- Lanzhou, China 2 trialsAll trials in Lanzhou, China
- Qingdao, China 2 trialsAll trials in Qingdao, China
- Boston, United States 2 trialsAll trials in Boston, United States
- Yuncheng, China 2 trialsAll trials in Yuncheng, China
- Chapel Hill, United States 2 trialsAll trials in Chapel Hill, United States
- New Delhi, India 2 trialsAll trials in New Delhi, India
- Wuhan, China 2 trialsAll trials in Wuhan, China
- Shenyang, China 2 trialsAll trials in Shenyang, China
- Qinghai, China 2 trialsAll trials in Qinghai, China
- Hangzhou, China 2 trialsAll trials in Hangzhou, China
- Hengyang, China 1 trialAll trials in Hengyang, China
- Kashgar, China 1 trialAll trials in Kashgar, China